<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04150003</url>
  </required_header>
  <id_info>
    <org_study_id>TEP-RR</org_study_id>
    <nct_id>NCT04150003</nct_id>
  </id_info>
  <brief_title>Study on the Effect of a Physical Training Structured Program After a Pulmonary Thromboembolism</brief_title>
  <acronym>TEP-RR</acronym>
  <official_title>Multicenter, Randomize Study to Evaluate the Effect of a Physical Training Structured Program After a Pulmonary Thromboembolism in the Restoration Lung Perfusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Pública Andaluza para la gestión de la Investigación en Sevilla</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación Pública Andaluza para la gestión de la Investigación en Sevilla</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Exercise training, as the core component of a Pulmonary Rehabilitation program, may help
      restore arterial blood flow in the lungs of patients who had suffered Pulmonary Embolism
      (PE), stimulating and promoting vasodilator effects, repairing the damaged endothelium and
      recruiting new blood vessels and also inducing a net fibrinolytic balance. Besides, exercise
      training could have a positive effect on quality of life of these patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An experimental multicenter study is proposed , randomized according to parallel assignation
      and blinded to third ones to evaluate the effect of a 10-weeks structured exercise-based
      intervention protocol on the restoration of lung blood flow after an acute PE.

      Main objective is to compare the efficacy and safety in terms of quantitative measures from
      lung scintigraphy, of lung perfusion versus usual care in patients with PE. Additionally the
      study is aimed to identify bio-markers of response to treatment (mRNAs, MPs and proteomic
      approach) and to analyze the effects of training on exercise capacity, quality of life
      parameters and anxiety depression scores.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2019</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the rate of lung perfusion defects after PE</measure>
    <time_frame>Baseline up to one month after the episode of PE, final after 12 weeks of randomization</time_frame>
    <description>Lung scintigraphy of lung perfusion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Identification of biomarkers of response to treatment</measure>
    <time_frame>The day the randomization occurs and the final visit after 12 weeks of the randomization</time_frame>
    <description>Changes from baseline in the determination of mRNAs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Identification of another biomarkers of response to treatment</measure>
    <time_frame>The day the randomization occurs and the final visit after 12 weeks of the randomization</time_frame>
    <description>Changes from baseline in the determination of MPs (Microparticle (MP) Microparticles (MPs)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the percent predicted peak oxygen uptake (VO2 peak) after PE</measure>
    <time_frame>Baseline up to one month after the episode of PE, final after 12 weeks of randomization</time_frame>
    <description>Peak Oxygen uptake (VO2 peak) is obtained from Cardiopulmonary Exercise Test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the EuroQol scale</measure>
    <time_frame>Baseline up to one month after the episode of PE, final after 12 weeks of randomization</time_frame>
    <description>Visual analog score (0-100, lower score indicate worse outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the PEmb-QoL questionnaire by a PEmb-QoL -</measure>
    <time_frame>&quot;Baseline up to one month after the episode of PE, final after 12 weeks of randomization</time_frame>
    <description>PEmb-QoL summary score (0-100, higher score indicate worse outcome)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Pulmonary Embolism</condition>
  <arm_group>
    <arm_group_label>Pulmonary Rehabilitation program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10-weeks structured exercise-based intervention protocol on the restoration of lung blood flow after an acute PE</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Protocolized usual care for patient suffering PE</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Pulmonary Rehabilitation program</intervention_name>
    <description>Structured rehabilitation program of directed exercises</description>
    <arm_group_label>Pulmonary Rehabilitation program</arm_group_label>
    <other_name>Rehabilitation program</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual care</intervention_name>
    <description>Usual care for patients who had suffered a Pulmonary Embolism</description>
    <arm_group_label>Usual care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients 18 years or older at PE diagnosis PE diagnosis confirmed by imaging tests
        according guidelines Patients under correct anticoagulant treatment Persistent Lung
        Perfusion Defects at one month after PE diagnosis. Signed Consent Inform

        Exclusion Criteria:

        Incidental or silent PE Pregnant or puerperal woman Life expectancy less than 6 months
        Severe comorbidities (NYHA 4 in severe heart failure; COPD, gold D; severe psychiatric
        illness) Any disability for physical exercise according to their doctors

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Remedios Otero, MD-PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospitales Universitarios Virgen del Rocío</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Remedios Otero, Md-PHd</last_name>
    <phone>0034955012144</phone>
    <email>remeotero@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Clara Rosso-Fernández, MD-PhD</last_name>
    <phone>0034955012144</phone>
    <email>claram.rosso.sspa@juntadeandalucia.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital de Txagorritxu</name>
      <address>
        <city>Vitoria</city>
        <state>Alava</state>
        <zip>01009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>José Luis Lobo, MD</last_name>
      <email>joseluis.loboberistain@osakidetza.eus</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocio</name>
      <address>
        <city>Sevilla</city>
        <state>Andalucia</state>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Remedios Otero, MD</last_name>
      <email>remeotero@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Pilar Cejudo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Teresa Elias</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Isabel Asencio</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Verónica Sánchez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joaquin Ruiz</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luis Caballero</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen Macarena</name>
      <address>
        <city>Sevilla</city>
        <zip>41009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Virginia Almadana</last_name>
    </contact>
    <investigator>
      <last_name>Gertrudis Sabadell</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patricia Guerrero</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Isabel Blasco</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mercedes Vaquero</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yolanda López</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 22, 2019</study_first_submitted>
  <study_first_submitted_qc>October 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2019</study_first_posted>
  <last_update_submitted>October 31, 2019</last_update_submitted>
  <last_update_submitted_qc>October 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Venous Thromboembolic Disease</keyword>
  <keyword>Pulmonary Embolism</keyword>
  <keyword>Rehabilitation program</keyword>
  <keyword>Exercise training</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Results to be published in impact factor journals</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>After the end of analysis and publication of results</ipd_time_frame>
    <ipd_access_criteria>collaborators in the design and performance of the study</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

